Tae S. Sohn

Uijeongbu St Mary's Hospital
Uijeongbu-si, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Financial burden of glycemic control: a single-center retrospective study of diabetes costs in South Korean patients.

Financial burden of glycemic control: a single-center retrospective study of diabetes costs in South Korean patients.

Journal: The Korean journal of internal medicine

Published: July 22, 2025

Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52-week, multicentre, randomized, placebo-controlled, phase III clinical trial.

Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52-week, multicentre, randomized, placebo-controlled, phase III clinical trial.

Journal: Diabetes, obesity & metabolism

Published: May 08, 2025

A 52-week efficacy and safety study of enavogliflozin versus dapagliflozin as an add-on to metformin in patients with type 2 diabetes mellitus: ENHANCE-M extension study.

A 52-week efficacy and safety study of enavogliflozin versus dapagliflozin as an add-on to metformin in patients with type 2 diabetes mellitus: ENHANCE-M extension study.

Journal: Diabetes, obesity & metabolism

Published: November 26, 2023

Deep Learning Analysis With Gray Scale and Doppler Ultrasonography Images to Differentiate Graves' Disease.

Deep Learning Analysis With Gray Scale and Doppler Ultrasonography Images to Differentiate Graves' Disease.

Journal: The Journal of clinical endocrinology and metabolism

Published: September 04, 2023

Real-World Treatment Patterns according to Clinical Practice Guidelines in Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Korea: Multicenter, Retrospective, Observational Study.

Real-World Treatment Patterns according to Clinical Practice Guidelines in Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Korea: Multicenter, Retrospective, Observational Study.

Journal: Diabetes & metabolism journal

Published: July 13, 2023

Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial.

Efficacy and Safety of Enavogliflozin versus Dapagliflozin as Add-on to Metformin in Patients with Type 2 Diabetes Mellitus: A 24-Week, Double-Blind, Randomized Trial.

Journal: Diabetes & metabolism journal

Published: September 09, 2022

Young-onset type 2 diabetes in South Korea: a review of the current status and unmet need.

Young-onset type 2 diabetes in South Korea: a review of the current status and unmet need.

Journal: The Korean journal of internal medicine

Published: August 17, 2021

Age at Diagnosis and the Risk of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus (Diabetes Metab J 2021;45:46-54).

Age at Diagnosis and the Risk of Diabetic Nephropathy in Young Patients with Type 1 Diabetes Mellitus (Diabetes Metab J 2021;45:46-54).

Journal: Diabetes & metabolism journal

Published: April 05, 2021

Hemorrhoids Are Associated with Urinary Incontinence.

Hemorrhoids Are Associated with Urinary Incontinence.

Journal: Journal of women's health (2002)

Published: August 09, 2020

Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus.

Long-Term Glycaemic Durability of Early Combination Therapy Strategy versus Metformin Monotherapy in Korean Patients with Newly Diagnosed Type 2 Diabetes Mellitus.

Journal: Diabetes & metabolism journal

Published: July 20, 2020

Smoking as a Target for Prevention of Diabetes.

Smoking as a Target for Prevention of Diabetes.

Journal: Diabetes & metabolism journal

Published: July 03, 2020

Letter: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019;43:582-9).

Letter: Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2019;43:582-9).

Journal: Diabetes & metabolism journal

Published: January 06, 2020

Showing 1-12 of 28

Last Updated: 09/26/2026